Mutation at Histidine 338 of gp91 Depletes FAD and Affects Expression of Cytochrome b 558 of the Human NADPH Oxidase

Lucia S. Yoshida, Fumiko Saruta, Ken Yoshikawa, Osamu Tatsuzawa, Shohko Tsunawaki

Journal of Biological Chemistry · 1998 · 52 citations · 52 references

DOIFull text

Open access

Concepts

Abstract

Defective NADPH oxidase components prevent superoxide (O⨪2) generation, causing chronic granulomatous disease (CGD). X-linked CGD patients have mutations in the gene encoding the gp91phox subunit of cytochromeb 558 and usually lack gp91phox protein completely (X910). gp91phox is considered to be a flavocytochrome that contains binding sites for NADPH, FAD, as well as heme. We here report a rare X-linked CGD patient whose neutrophils entirely failed to produce O⨪2, but presented a diminished expression of gp91phox containing about one-third of the heme present in normal individuals by Soret absorption. Translocation of cytosolic factors p67phox and p47phox was normal. However, the FAD content in his neutrophil membranes was as low as that of X910patients, suggesting complete depletion of FAD in his gp91phox. This was in agreement with the finding that a single base substitution (C1024 to T) changed His-338 to Tyr in gp91phox in a predicted FAD-binding domain of the flavocytochrome model. The loss of FAD could not be corrected even after addition of reagent FAD or a FAD-rich dehydrogenase fraction isolated from normal neutrophils to the patient's membranes, in a reconstitution in vitro with normal cytosol. These results indicate that His-338 is a very critical residue for FAD incorporation into the NADPH oxidase system. This is the first such mutation found in CGD. Defective NADPH oxidase components prevent superoxide (O⨪2) generation, causing chronic granulomatous disease (CGD). X-linked CGD patients have mutations in the gene encoding the gp91phox subunit of cytochromeb 558 and usually lack gp91phox protein completely (X910). gp91phox is considered to be a flavocytochrome that contains binding sites for NADPH, FAD, as well as heme. We here report a rare X-linked CGD patient whose neutrophils entirely failed to produce O⨪2, but presented a diminished expression of gp91phox containing about one-third of the heme present in normal individuals by Soret absorption. Translocation of cytosolic factors p67phox and p47phox was normal. However, the FAD content in his neutrophil membranes was as low as that of X910patients, suggesting complete depletion of FAD in his gp91phox. This was in agreement with the finding that a single base substitution (C1024 to T) changed His-338 to Tyr in gp91phox in a predicted FAD-binding domain of the flavocytochrome model. The loss of FAD could not be corrected even after addition of reagent FAD or a FAD-rich dehydrogenase fraction isolated from normal neutrophils to the patient's membranes, in a reconstitution in vitro with normal cytosol. These results indicate that His-338 is a very critical residue for FAD incorporation into the NADPH oxidase system. This is the first such mutation found in CGD. chronic granulomatous disease cell equivalent chemiluminescence Epstein-Barr virus ferredoxin-NADP+ reductase guanosine 5′-(γ-O-thio)-triphosphate p-iodonitrotetrazolium violet nitro blue tetrazolium phosphate-buffered saline containing 5 mm glucose (pH 7.4) peptide:N-glycosidase F photostimulative luminescence 1,4-piperazinediethanesulfonic acid polyacrylamide gel electrophoresis polyvinylidene difluoride. The respiratory burst of phagocytes for production of reactive oxygen intermediates is an important participant in host defense. Activation of the responsible enzyme, NADPH oxidase, requires the assembly of a membrane-integrated cytochromeb 558 (a heterodimer formed by gp91phox and p22phox) with cytosolic components p47phox and p67phox under control of the small GTP-binding protein Rac (for reviews, see Refs. 1Thrasher A.J. Keep N.H. Wientjes F. Segal A.W. Biochim. Biophys. Acta. 1994; 1227: 1-24Crossref PubMed Scopus (212) Google Scholar, 2Chanock S.J. el Benna J. Smith R.M. Babior B. J. Biol. Chem. 1994; 269: 24519-24522Abstract Full Text PDF PubMed Google Scholar, 3De Leo F.R. Quinn M.T. J. Leukocyte Biol. 1996; 60: 677-691Crossref PubMed Scopus (460) Google Scholar). Recently, we and others found a third phox-protein, p40phox, which forms a complex unit with p67phox(4Someya A. Nagaoka I. Yamashita T. FEBS Lett. 1993; 330: 215-218Crossref PubMed Scopus (72) Google Scholar, 5Wientjes F.B. Hsuan J.J. Totty N.F. Segal A.W. Biochem. J. 1993; 296: 557-561Crossref PubMed Scopus (262) Google Scholar, 6Tsunawaki S. Mizunari H. Nagata M. Tatsuzawa O. Kuratsuji T. Biochem. Biophys. Res. Commun. 1994; 199: 1378-1387Crossref PubMed Scopus (97) Google Scholar). Defects in the components excepting Rac and p40phox are so far responsible for chronic granulomatous disease (CGD),1a hereditary syndrome characterized by life-threatening recurrent infections and chronic inflammation with granuloma formation. The most common form of CGD is X-linked, which is caused by mutations in the gene encoding gp91phox. Mutations in other oxidase components are all autosomal forms (genes of p22phox, p47phox, and p67phox; for review, see Ref. 7Roos D. de Boer M. Kuribayashi F. Meischl C. Weening R.S. Segal A.W. Åhlin A. Nemet K. Hossle J.P. Berantowska-Matuszkiewicz E. Middleton-Price H. Blood. 1996; 87: 1663-1681Crossref PubMed Google Scholar). Cytochrome b 558, the redox center of the NADPH oxidase (8Knoller S. Shpungin S. Pick E. J. Biol. Chem. 1991; 266: 2795-2804Abstract Full Text PDF PubMed Google Scholar), is thought to contain at least two hemes (9Quinn M.T. Mullen M.L. Jesaitis A.J. J. Biol. Chem. 1992; 267: 7303-7309Abstract Full Text PDF PubMed Google Scholar, 10Cross A.R. Rae J. Curnutte J.T. J. Biol. Chem. 1995; 270: 17075-17077Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar) of low spin (11Fujii H. Kakinuma K. Biochim. Biophys. Acta. 1992; 1136: 239-246Crossref PubMed Scopus (14) Google Scholar, 12Miki T. Fujii H. Kakinuma K. J. Biol. Chem. 1992; 267: 19673-19675Abstract Full Text PDF PubMed Google Scholar, 13Isogai Y. Iizuka T. Makino R. Iyanagi T. Orii Y. J. Biol. Chem. 1993; 268: 4025-4031Abstract Full Text PDF PubMed Google Scholar), each coordinated by two histidines in the resting state (14Fujii H. Finnegan M.G. Miki T. Crouse B.R. Kakinuma K. Johnson M.K. FEBS Lett. 1995; 377: 345-348Crossref PubMed Scopus (18) Google Scholar). This hexacoordinated state seems to change to a pentacoordinated form upon the activation of the NADPH oxidase (15Doussière J. Gaillard J. Vignais P.V. Biochemistry. 1996; 35: 13400-13410Crossref PubMed Scopus (62) Google Scholar), allowing oxygen to access and then to be reduced to superoxide anion (O⨪2). There have been some speculations on axial histidine ligands based on the analysis of mutations occurring in CGD patients whose neutrophils are devoid of heme (7Roos D. de Boer M. Kuribayashi F. Meischl C. Weening R.S. Segal A.W. Åhlin A. Nemet K. Hossle J.P. Berantowska-Matuszkiewicz E. Middleton-Price H. Blood. 1996; 87: 1663-1681Crossref PubMed Google Scholar, 16Bolscher B.G.J.M. de Boer M. de Klein A. Weening R.S. Roos D. Blood. 1991; 77: 2482-2487Crossref PubMed Google Scholar) or present an abnormal heme spectrum (10Cross A.R. Rae J. Curnutte J.T. J. Biol. Chem. 1995; 270: 17075-17077Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar), as well as by comparison of amino acid sequences with otherb-type cytochromes (17Finegold A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar, 18Porter C.D. Kuribayashi F. Parkar M.H. Roos D. Kinnon C. Biochem. J. 1996; 315: 571-575Crossref PubMed Scopus (28) Google Scholar). From these studies, hemes were supposed to be either within gp91phox alone (17Finegold A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar) or distributed in both subunits with a possible sharing between gp91phox and p22phox (9Quinn M.T. Mullen M.L. Jesaitis A.J. J. Biol. Chem. 1992; 267: 7303-7309Abstract Full Text PDF PubMed Google Scholar,18Porter C.D. Kuribayashi F. Parkar M.H. Roos D. Kinnon C. Biochem. J. 1996; 315: 571-575Crossref PubMed Scopus (28) Google Scholar), involving the invariable His-94 in the latter. However, most of the mutations occurring in candidate His residues for axial ligation to hemes in gp91phox (His-101, -209, and -222) lead to complete absence of cytochrome b 558 protein and of (7Roos D. de Boer M. Kuribayashi F. Meischl C. Weening R.S. Segal A.W. Åhlin A. Nemet K. Hossle J.P. Berantowska-Matuszkiewicz E. Middleton-Price H. Blood. 1996; 87: 1663-1681Crossref PubMed Google Scholar, 16Bolscher B.G.J.M. de Boer M. de Klein A. Weening R.S. Roos D. Blood. 1991; 77: 2482-2487Crossref PubMed Google Scholar). the sites of axial histidine ligands to the are not gp91phox is considered to contain redox for both NADPH A.W. I. Wientjes F. A.J. B. H. Biochem. J. 1992; PubMed Scopus Google Scholar, F. Biochem. Biophys. Res. Commun. 1993; PubMed Scopus Google Scholar, J. Vignais P.V. Biochemistry. 1993; PubMed Scopus Google Scholar) and FAD Pick E. FEBS Lett. 1994; Scopus Google Scholar, J. Vignais P.V. Biochemistry. 1995; PubMed Scopus Google Scholar, Y. H. J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar). This flavocytochrome was first based on the between the amino acid sequences of gp91phox and of the ferredoxin-NADP+ reductase A.W. I. Wientjes F. A.J. B. H. Biochem. J. 1992; PubMed Scopus Google Scholar, D. 1992; PubMed Scopus Google Scholar, H. M. Y. K. S. Biochem. Biophys. Res. Commun. 1992; PubMed Scopus Google Scholar). However, mutations that the of gp91phox in FAD binding are not We found an X-linked CGD patient whose neutrophils cytochrome b 558 containing with a diminished of gp91phox protein but a of patient was entirely of FAD in his neutrophil of the mutation of His-338 to Tyr in his which in a domain predicted to be with FAD in the flavocytochrome Segal A.W. 1993; PubMed Scopus Google Scholar). This is in Y. Biochim. Biophys. Acta. 1995; PubMed Scopus Google Scholar) and gp91phox H. Blood. 1996; 87: PubMed Google Scholar) and in a of in (17Finegold A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar), with which gp91phox a on the of results that His-338 in a critical for the of cytochromeb 558, for FAD binding and but not with cytosolic Cytochrome p-iodonitrotetrazolium violet nitro blue tetrazolium acid and were from for were from for gel electrophoresis were from were from and were from from was after a with other were of patients in were by for of to produce as well as complete absence of both cytochromeb 558 subunits on a to was from patients of generation, his neutrophils presented of gp91phox on His and were as to of of normal on and by The NADPH oxidase were as S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar). was from normal and CGD patients with to by and in phosphate-buffered saline containing 5 mm glucose Ref. S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar). isolated by were with Epstein-Barr virus from cell J. Google Scholar). The as well as the were for of and neutrophils for neutrophils were from were with mm for on with and at in mm mm mm and containing and mm after cell to Ref. S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar, were to and to polyvinylidene membranes with of in of p47phox, p22phox, and p40phox as S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar, S. S. K. Kuratsuji T. H. J. 1996; PubMed Scopus Google Scholar). the gp91phox was by of of were with a 558 subunits were by of on a of expression of cytochromeb 558 subunits in patient was with membranes, by of at for at were for heme as and subunits were by of as a The were after to which were in a The photostimulative luminescence for normal gp91phox and p22phox were the heme in each to The of protein was after of all from gp91phox with peptide:N-glycosidase F to the membranes were with of F for at and by analysis with was isolated from either or of patient as well as normal by with by Biochem. PubMed Scopus Google Scholar). was by of to of in of mm mm and mm with either or as by the the gp91phox to to Ref. PubMed Google Scholar) was by in the from a report Curnutte J.T. H. J. PubMed Scopus Google and and and The of the first of each and of in The were as of for for and for by a at These were into as by the and The from were by with on were from both and and were by in Ref. J. T. acid or was on in were with of in a to the of of of cytochrome b were in the of a were at after addition of a of of A.R. Segal A.W. Biochem. J. PubMed Scopus Google Scholar) for the and that of C. Biochemistry. PubMed Scopus Google Scholar) for the Soret were for The heme of membranes were after by as excepting that was 5 to was by the Soret absorption. were in with chemiluminescence of with mm and and These membranes were then in the and at of were by the T. Kakinuma K. Biochim. Biophys. Acta. 1992; PubMed Scopus Google Scholar). FAD was after to by with in of mm at of which at and after addition were then to The of and in was at and the were at on a to a in the of to of was within the of to The of FAD in as small as of membranes could be by and presented after of T. Kakinuma K. Biochim. Biophys. Acta. 1992; PubMed Scopus Google Scholar). was to the of as a This was to Ref. A.J. de J. Biol. Chem. 1993; 268: Full Text PDF PubMed Google membranes were with normal from as S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar) and with in the of in a of of activation mm containing mm mm and mm a at the were on a each of in activation The fraction at was with then in a containing and mm and for 5 at The of cytosolic factors was by of cytochrome b 558 was with The of the patient's cytochrome b 558 in neutrophil membranes was in a with normal cytosol. membranes were with either reagent FAD or an fraction at b of The a FAD-rich fraction of was isolated from normal to Ref. T. Kakinuma K. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar, of the The FAD content in the fraction was by the of in a were for heme by with activation and with reagent FAD, an or both activation in a with acid and of cytosol. was with a b 558 heme of on (for see NADPH and are presented after of with under the not in a were for heme by with activation and with reagent FAD, an or both activation in a with acid and of cytosol. was with a b 558 heme of on (for see NADPH and are presented after of with under the not in vitro the membranes with either reagent FAD or the fraction were with of and in to of activation and with acid for 5 at These membranes were then to of activation with NADPH and the of NADPH was by the in the at was as an A.R. Curnutte J.T. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar), activation was under low oxygen by and of mm glucose glucose was at was to be a of X-linked CGD to of his on an in which his and presented a This was by the the patient's neutrophils entirely failed to produce and of his presented about of the of normal that the was in a was by an normal expression of the cytosolic factors oxidase of of in were with and was by superoxide cytochrome are in of two in a in were with and was by superoxide cytochrome are in of two Mutations in X-linked CGD usually lead to expression of gp91phox protein to of as in patients completely lack subunit neutrophils of patient gp91phox of by characterized by a of of the of low very the after of with F in his and in normal individuals and in either gp91phox or p22phox usually in of the the of is important for the of each with patient neutrophils was at of control a the of control present in patients and However, the of p22phox and gp91phox Segal A.W. Biochem. J. 1996; PubMed Scopus Google Scholar), p22phox was present from of gp91phox on This was as of cytochromeb 558 of normal neutrophils an at 558 and a Soret at first neutrophils of patient not to the at 558 and we thought that his cytochrome b 558 was in an devoid of heme. However, his spectrum was with that of an we that the Soret was such a in could be on and reduced to the heme content in neutrophils one-third the found in normal individuals on Soret and on was to This was about the heme present in his content of 558 of the of are were at in the of cytochrome b 558 was by the at as well as that at on as in the of are in a were at in the of cytochrome b 558 was by the at as well as that at on as in such heme were with of cytochrome b 558, we to heme be from the of both subunits on with a was with normal membranes, from subunits heme by The of gp91phox was in the of to of heme but that of p22phox of heme membranes presented p22phox to results in A. of heme of each membranes of p22phox in and but a reduced gp91phox in the of his gp91phox and p22phox into heme on in protein expression of p22phox of was in agreement with an NADPH heme of of heme Soret as a see that of gp91phox was low of the patient is a very in which gp91phox is but cytochrome b 558 in membranes of X-linked CGD are the after of heme and FAD of are the after of heme and FAD of are the after of heme and FAD of of was from the Soret on and FAD was in the by chemiluminescence are the after of heme and FAD of in a was from the Soret on and FAD was in the by chemiluminescence The gp91phox of patient from either his or was to and in on that the from the patient the normal in of normal of for the of from a mutation at to in a amino acid His-338 to Tyr in the This mutation was found in all for from and from other mutations were found in the and of gp91phox. of the X-linked of by his and as well as a expression of p22phox on and gene was not His-338 was in a to be with FAD in the flavocytochrome of gp91phox Segal A.W. 1993; PubMed Scopus Google Scholar) and a His with in heme we the FAD content in patient's membranes was FAD in neutrophil membranes after by cytosolic The FAD content on of cytochromeb 558, as by whose FAD was to protein of in normal the FAD content of patient membranes on two was as low as in of his expression of in neutrophil of patient the of with two from on is FAD was by the chemiluminescence under not which to of of in membranes from the of are patient the of with two from on is in a FAD was by the chemiluminescence under not which to of of in membranes from the of are which of the was FAD or we heme in the heme were from the Soret and were in agreement with in neutrophils of heme and FAD in the patient were in both to of However, after such FAD was in membranes, heme at of normal The which were from a normal of to after the a was in normal and the These results a depletion of FAD of heme in the the of the patient's cytochrome b 558 to cytosolic factors was an in system. from of p22phox between and normal a normal was with the patient's that both p67phox and p47phox could with cytochrome b 558 in to at least the for activation of the NADPH oxidase, of cytosolic factors to cytochrome b 558, The was the patient's cytochromeb 558, at His-338 in the FAD-binding to FAD was in a system. We by reagent FAD or a FAD-rich to be to the NADPH oxidase of cytochrome b 558 reagent FAD T. Kakinuma K. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). the fraction with S. Mizunari H. H. Kuratsuji T. J. 1994; PubMed Scopus Google Scholar) and sites cytochrome to in cytochrome b 558, T. Kakinuma K. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar, Segal A.W. Biochem. J. 1996; PubMed Scopus Google Scholar, Y. Y. A. Iizuka T. J. Biol. Chem. 1991; 266: Full Text PDF PubMed Google Scholar, Y. H. S. Biochem. J. 1994; PubMed Scopus Google Scholar). This indicate or not at least with an dehydrogenase could be and on the patient's heme was membranes at a of with reagent FAD, or The containing protein of and FAD in a of was to with normal cytochrome b 558, NADPH and was FAD alone of FAD were not of FAD for reconstitution of redox in the system. the the patient's even with both the which to FAD and FAD from of which from reduced FAD of the oxidase A.R. Curnutte J.T. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar), was in patient absence of a FAD in his NADPH The results that be by on very in neutrophils of X-linked CGD patient and His of gp91phox and cytochromeb 558 heme were with from patients with a form of oxidase to heme D. de Boer M. N.H. T. Weening R.S. J. Leukocyte Biol. 1992; PubMed Scopus Google Scholar). However, the NADPH oxidase was completely in patient so that his is in the of CGD in the that a single residue substitution so of gp91phox by as well as the of diminished of protein after seems of gp91phox is a the other p22phox was not as diminished as gp91phox and an expression of the two subunits of cytochrome b 558 that gp91phox is p22phox, to the The substitution of His-338 by Tyr in the patient's gp91phox not to of cytosolic factors with cytochromeb 558 as from the is of sites for cytochromeb 558 with p47phox 3De Leo F.R. Quinn M.T. J. Leukocyte Biol. 1996; 60: 677-691Crossref PubMed Scopus (460) Google which with This is in agreement with the of the NADPH oxidase in a by a that His-338 S. H. S. Biochem. Biophys. Res. Commun. PubMed Scopus Google Scholar). the mutation could be cytochromeb 558 as to of redox in FAD and heme and of the gp91phox The are to the that the patient's gp91phox is in the redox for of binding FAD was in membranes and heme The Soret in neutrophils as well as in his membranes of heme in heme with p22phox gp91phox that in hemes were to the of p22phox, that p22phox in ligation of at least of the hemes in cytochrome b the other of FAD loss of hemes could be by reconstitution even by reagent FAD and an reductase to NADPH These results to the flavocytochrome Segal A.W. 1993; PubMed Scopus Google Scholar), at His-338 in the binding is to FAD and to in the the reconstitution of between cytochromeb 558 and an the mutation such an and even not with either FAD or is that mutation the within redox in lack of a for FAD, the first two From these be that the is completely in His-338 is in a of gp91phox 5 to a in a for FAD to Segal A.W. 1993; PubMed Scopus Google Scholar). of FAD depletion in the patient's membranes with the His-338 and of gp91phox to residues and in A.W. I. Wientjes F. A.J. B. H. Biochem. J. 1992; PubMed Scopus Google Scholar, Segal A.W. 1993; PubMed Scopus Google Scholar) and are with and of of are at least residues in the binding of which some have and of the in H. K. Miki K. FEBS Lett. 1995; PubMed Scopus Google Scholar), with and in 5 B. However, in the 5 of the FAD-binding domain of gp91phox Ref. Segal A.W. 1993; PubMed Scopus Google Scholar) with that of of these residues with the amino in of which an the is from an of that residues with be of a of in other Curnutte J.T. 1992; Full Text PDF PubMed Google Scholar), and some to gp91phox in the as in A.J. Keep N.H. Wientjes F. Segal A.W. Biochim. Biophys. Acta. 1994; 1227: 1-24Crossref PubMed Scopus (212) Google Scholar, absence of F and of in gp91phox that the binding of FAD by the to be However, are the first that is critical for FAD a mutation of a we about of His-338 a in heme This His is a residue in the protein (17Finegold A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar), to which gp91phox a was in and the in was to FAD A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google see 5 least in seems not to be in heme axial as an at presented of heme in a (17Finegold A.A. Shatwell K.P. Segal A.W. Klausner R.D. Dancis A. J. Biol. Chem. 1996; 271: 31021-31024Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). However, heterodimer with p22phox in cytochromeb 558 with is that the mutations of amino in or to the to His T. Y. S. 1994; PubMed Scopus Google Scholar), to D. Curnutte J.T. Hossle J.P. T. H. M. Segal A.W. M. Keep N.H. R. 1996; PubMed Google Scholar), and to (7Roos D. de Boer M. Kuribayashi F. Meischl C. Weening R.S. Segal A.W. Åhlin A. Nemet K. Hossle J.P. Berantowska-Matuszkiewicz E. Middleton-Price H. Blood. 1996; 87: 1663-1681Crossref PubMed Google in which all 5 substitution of His-338 by Tyr expression of protein with heme. is that Tyr at axial histidines and in cytochromeb 558, which hemes with presented heme H. PubMed Scopus Google Scholar) of could as an axial for heme. However, these the cytochrome b to with dehydrogenase and to absence of these subunits in the membranes H. PubMed Scopus Google Scholar). the that His-338 in gp91phox could as an axial for a heme between gp91phox and p22phox subunits of cytochromeb 558 be completely the of and the loss of in membranes and as a of lack of an and the the other mutations protein but not that of His-338 to The expression of gp91phox in patient that the containing His-338 for protein with p22phox of cytochromeb This is by the expression of of with forms in the mutation C.D. Kuribayashi F. Parkar M.H. Roos D. Kinnon C. Biochem. J. 1996; 315: 571-575Crossref PubMed Scopus (28) Google Scholar). a to forms is in neutrophils in C.D. Parkar M.H. A.J. Kinnon C. Blood. 1994; PubMed Google Scholar), is possible that such forms and could not be in and low of the protein His-338 was to be very critical for cytochromeb 558 for a of FAD in the NADPH to be which of the is the of CGD but the of the of gp91phox in FAD based on the flavocytochrome model. We are to H. for

References

52